{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:57:29Z","timestamp":1761919049972},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,10,16]],"date-time":"2007-10-16T00:00:00Z","timestamp":1192492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00330-007-0781-0","type":"journal-article","created":{"date-parts":[[2007,10,15]],"date-time":"2007-10-15T04:52:48Z","timestamp":1192423968000},"page":"468-476","source":"Crossref","is-referenced-by-count":21,"title":["Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases"],"prefix":"10.1007","volume":"18","author":[{"given":"Thomas J.","family":"Vogl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Zangos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Bayne","family":"Selby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,16]]},"reference":[{"issue":"4","key":"781_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/02841860310000412","volume":"42","author":"S Nucum","year":"2003","unstructured":"Nucum S, Midgley R, Kerr DJ (2003) Colorectal cancer. Acta Oncol 42(4):263\u2013275","journal-title":"Acta Oncol"},{"issue":"1","key":"781_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-005-9039-1","volume":"96","author":"MHR Eichbaum","year":"2006","unstructured":"Eichbaum MHR, Kaltwasser M, Bruckner T, de Rossi TM, Schneeweiss A, Sohn Ch (2006) Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 96(1):53\u201362","journal-title":"Breast Cancer Res Treat"},{"key":"781_CR3","first-page":"225","volume-title":"Mammakarzinome - Empfehlungen zur Diagnostik, Therapie und Nachsorge","author":"V Heinemann","year":"2005","unstructured":"Heinemann V, Artmann A, Beinert T, Dietzfelbinger H, Eiermann W, Gabius S, Harbeck N, Kahlert S, Kau W, Lombardo SM, Lorenz T, Merz P, Pihusch R, Rauthe C, Sattler D, Sauer H, Untch M, Wolf C (2005) Systemische Therapie des metastasierten Mammakarzinoms. In: Sauer H, Tumorzentrum Muenchen (ed) Mammakarzinome - Empfehlungen zur Diagnostik, Therapie und Nachsorge. Zuckschwerdt, Muenchen, pp 225\u2013241"},{"key":"781_CR4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"SA Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303\u20131314","journal-title":"Lancet"},{"key":"781_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1634\/theoncologist.9-1-43","volume":"9","author":"CD Anderson","year":"2004","unstructured":"Anderson CD, Pinson CW, Berlin J, Chari RS (2004) Diagnosis and treatment of cholangiocarcinoma. Oncologist 9:43\u201357","journal-title":"Oncologist"},{"issue":"7","key":"781_CR6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0959-8049(97)10166-6","volume":"34","author":"M Hejna","year":"1998","unstructured":"Hejna M, Pruckmayer M, Raderer M (1998) The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 34(7):977\u2013986","journal-title":"Eur J Cancer"},{"issue":"4","key":"781_CR7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00330-006-0372-5","volume":"17","author":"TJ Vogl","year":"2007","unstructured":"Vogl TJ, Zangos S, Eichler K, Yakoub D, Nabil M (2007) Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol 17(4):1025\u20131034","journal-title":"Eur Radiol"},{"key":"781_CR8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jnci\/80.2.84","volume":"80","author":"RL Dedrick","year":"1988","unstructured":"Dedrick RL (1988) Arterial drug infusion: pharmacokinetic problems and pitfalls. J Natl Cancer Inst 80:84\u201389","journal-title":"J Natl Cancer Inst"},{"key":"781_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-82025-0_1","volume":"86","author":"FO\/ Stephens","year":"1983","unstructured":"Stephens FO (1983) Pharmacokinetics of intraarterial chemotherapy. Recent Results Cancer Res 86:1\u201312","journal-title":"Recent Results Cancer Res"},{"key":"781_CR10","first-page":"31","volume":"64","author":"HSG Chen","year":"1980","unstructured":"Chen HSG, Gross JF (1980) Intraarterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64:31\u201340","journal-title":"Cancer Treat Rep"},{"key":"781_CR11","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/1097-0142(19891201)64:11<2203::AID-CNCR2820641103>3.0.CO;2-O","volume":"64","author":"A Schneider","year":"1989","unstructured":"Schneider A, Kemeny N, Chapman D, Niedzwiecki D, Odermann P (1989) Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal cancer. Cancer 64:2203\u20132206","journal-title":"Cancer"},{"key":"781_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer E, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian CM, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"781_CR13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1445-1433.2004.03148.x","volume":"74","author":"D Damjanovic","year":"2004","unstructured":"Damjanovic D, Thompson P, Findlay MPN (2004) Evidence-based update of chemotherapy options for metastatic colorectal cancer. ANZ J Surg 74:781\u2013787","journal-title":"ANZ J Surg"},{"issue":"9","key":"781_CR14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ejso.2005.03.015","volume":"31","author":"D Lawes","year":"2005","unstructured":"Lawes D, Taylor I (2005) Chemotherapy for colorectal cancer\u2014an overview of current management for surgeons. Eur J Surg Oncol 31(9):932\u2013941","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 3","key":"781_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000088480","volume":"69","author":"H Hurwitz","year":"2005","unstructured":"Hurwitz H, Kabbinavar F (2005) Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer. Oncology 69(Suppl 3):17\u201324","journal-title":"Oncology"},{"issue":"3","key":"781_CR16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-199754030-00009","volume":"54","author":"S Noble","year":"1997","unstructured":"Noble S, Goa KL (1997) Gemcitabine\u2014a review of its pharmacology and clinical potential in non-small lung cancer and pancreatic cancer. Drugs 54(3):447\u2013472","journal-title":"Drugs"},{"issue":"6","key":"781_CR17","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris","year":"1997","unstructured":"Burris HA, Moore MJ, Anderson J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson F, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403\u20132413","journal-title":"J Clin Oncol"},{"key":"781_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.20286","volume":"91","author":"N Kemeny","year":"2005","unstructured":"Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P (2005) Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 91:97\u2013101","journal-title":"J Surg Oncol"},{"key":"781_CR19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","volume":"24","author":"NE Kemeny","year":"2006","unstructured":"Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang C, Mayer RJ (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395\u20131403","journal-title":"J Clin Oncol"},{"key":"781_CR20","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1200\/JCO.2005.07.100","volume":"23","author":"N Kemeny","year":"2005","unstructured":"Kemeny N, Jarnagin W, Paty P, G\u00f6nen M, Schwartz L, Morse M, Leonard G, D\u2019Agnelica M, DeMatteo R, Blumgart L, Fong Y (2005) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23:4888\u20134896","journal-title":"J Clin Oncol"},{"key":"781_CR21","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","volume":"23","author":"M Ducreux","year":"2005","unstructured":"Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M (2005) Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the Gastrointestinal Group of the F\u00e9d\u00e9ration Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23:4881\u20134887","journal-title":"J Clin Oncol"},{"key":"781_CR22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1006308619659","volume":"59","author":"EF Solomayer","year":"2000","unstructured":"Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271\u2013278","journal-title":"Breast Cancer Res Treat"},{"key":"781_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1006285726561","volume":"56","author":"A Insa","year":"1999","unstructured":"Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J (1999) Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 56:67\u201378","journal-title":"Breast Cancer Res Treat"},{"key":"781_CR24","doi-asserted-by":"crossref","unstructured":"Elder EE, Kennedy CW, Gluch L, Carmalt HL, Janu NC, Joseph MG, Donellan MJ, Molland JG, Gilett DJ (2006) Patterns of breast cancer relapse. Eur J Surg Oncol. DOI 10.1016\/j.ejso.2006.06.001","DOI":"10.1016\/j.ejso.2006.06.001"},{"key":"781_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1308\/1478708051711","volume":"87","author":"AC Okaro","year":"2005","unstructured":"Okaro AC, Durkin DJ, Layer GT, Kissin MW, Karanjia ND (2005) Hepatic resection for breast cancer metastases. Ann R Coll Surg Engl 87:167\u2013170","journal-title":"Ann R Coll Surg Engl"},{"key":"781_CR26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0002-9610(02)01204-7","volume":"185","author":"D Elias","year":"2003","unstructured":"Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, Delaloge S (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185:158\u2013164","journal-title":"Am J Surg"},{"key":"781_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/ejso.1999.0778","volume":"26","author":"SM Maksan","year":"2000","unstructured":"Maksan SM, Lehnert T, Bastert G, Herfarth C (2000) Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 26:209\u2013212","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"781_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1024\/0040-5930.63.4.255","volume":"63","author":"BC Pestalozzi","year":"2006","unstructured":"Pestalozzi BC (2006) Mammakarzinom - therapeutische Fortschritte. Ther Umschau 63(4):255\u2013261","journal-title":"Ther Umschau"},{"key":"781_CR29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.10-90003-20","volume":"10","author":"J O\u2019Shaughnessy","year":"2005","unstructured":"O\u2019Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10:20\u201329","journal-title":"Oncologist"},{"issue":"1","key":"781_CR30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jjco\/29.1.23","volume":"29","author":"T Ikeda","year":"1999","unstructured":"Ikeda T, Adachi I, Takashima S, Ogita M, Aoyama H, Sano M, Ando J, Tabei T, Tominaga T, Enomoto K, Kanda K, Fukutomi T, Shimoyama M (1999) A phase I\/II study of continous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) Study 9113. Jpn J Clin Oncol 29(1):23\u201327","journal-title":"Jpn J Clin Oncol"},{"key":"781_CR31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00686687","volume":"33","author":"Y Arai","year":"1994","unstructured":"Arai Y, Sone Y, Inaba Y, Ariyoshi Y, Kido C (1994) Hepatic arterial infusion chemotherapy for liver metastases from breast cancer. Cancer Chemother Pharmacol 33:142\u2013144","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"781_CR32","first-page":"786","volume":"120","author":"M Lorenz","year":"1995","unstructured":"Lorenz M, Wiesener J, Staib-Sebler E, Encke A (1995) Regional therapy breast cancer liver metastases. Zentralbl Chir 120(10):786\u2013790","journal-title":"Zentralbl Chir"},{"issue":"suppl 5","key":"781_CR33","first-page":"159","volume":"123","author":"T Zimmermann","year":"1998","unstructured":"Zimmermann T, Flechsenhar K, Padberg W (1998) Value of locoregional chemotherapy in liver metastases of breast carcinoma. Zentralbl Chir 123(suppl 5):159\u2013161","journal-title":"Zentralbl Chir"},{"issue":"1","key":"781_CR34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jso.2930550108","volume":"55","author":"S Schneebaum","year":"1994","unstructured":"Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP (1994) The regional treatment of liver metastases from breast cancer. J Surg Oncol 55(1):26\u201332","journal-title":"J Surg Oncol"},{"issue":"suppl 2","key":"781_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/annonc\/mdi712","volume":"16","author":"S Thongprasert","year":"2005","unstructured":"Thongprasert S (2005) The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16 (suppl 2):93\u201396","journal-title":"Ann Oncol"},{"key":"781_CR36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1055\/s-2006-926869","volume":"44","author":"F Klebl","year":"2006","unstructured":"Klebl F, Endlicher E, Kullmann F (2006) Palliative Therapie von Gallengangs- und Gallenblasenkarzinomen. Z Gastroenterol 44:587\u2013598","journal-title":"Z Gastroenterol"},{"key":"781_CR37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0720-048X(01)00414-4","volume":"41","author":"N Tanaka","year":"2001","unstructured":"Tanaka N, Yamakado K, Nakatsuka A, Fujii A, Matsumura K, Takeda K (2001) Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma - initial experience. Eur J Radiol 41:42\u201348","journal-title":"Eur J Radiol"},{"key":"781_CR38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/cncr.20964","volume":"103","author":"M Cantore","year":"2005","unstructured":"Cantore M, Mambrini A, Fiorentini G, Rabbi C, Amagni D, Caudana R, Pennucci C, Sanguinetti F, Lombardi M, Nicoli N (2005) Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors. Cancer 103:1402\u20131407","journal-title":"Cancer"},{"key":"781_CR39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.RVI.0000143768.60751.78","volume":"16","author":"I Burger","year":"2005","unstructured":"Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JFH (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experiences in a single institution. J Vasc Interv Radiol 16:353\u2013361","journal-title":"J Vasc Interv Radiol"},{"key":"781_CR40","doi-asserted-by":"crossref","unstructured":"Vogl TJ, Schwarz W, Eichler K, Hochmuth K, Hammerstingl R, Jacob U, Scheller A, Zangos S, Heller M (2006) Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy. J Cancer Res Clin Oncol. DOI 10.1007\/s00432-006-0138-0","DOI":"10.1007\/s00432-006-0138-0"},{"issue":"Suppl 11","key":"781_CR41","first-page":"131","volume":"10","author":"HA Burris","year":"1996","unstructured":"Burris HA (1996) Objective outcome measures of quality of life. Oncology (Williston Park) 10(Suppl 11):131\u2013135","journal-title":"Oncology (Williston Park)"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-007-0781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-007-0781-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-007-0781-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:53:37Z","timestamp":1559030017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-007-0781-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,16]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s00330-007-0781-0","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,16]]}}}